The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

MDC Annual Neuromuscular ‘Seed Grant’ Competition Launch

MDC is very excited to announce that their Annual Neuromuscular ‘Seed Grant’ Competition has launched and are now accepting applications until Feb 2, 2021 for Translational Science Seed Grants and Clinical Health Management Grants.

 

During a time when health research funding is challenged due to the COVID-19 pandemic and as many like-minded organizations/agencies have had to cancel their research competitions, MDC are very grateful that they are able to continue the momentum achieved over the last several years and provide critical research funds to help accelerate the understanding of neuromuscular disorders, identify pathways for future therapies and optimize care to improve the quality of life for Canadians affected by neuromuscular disorders

 

For information on the scope and guidelines of this year’s competition, please visit:

https://muscle.ca/researchers/funding-guideline-deadlines/

 

Applications with cross-cutting applicability to multiple neuromuscular disorders under MDC’s umbrella as well as disorder-specific ones are welcomed. Special consideration will be given to relevant meritorious applications in the following disease-specific areas, through designated funds generously provided by donors: Myotonic Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Immune-mediated Myopathies, Charcot-Marie-Tooth Disease, Pediatric Neuromuscular Disorders.

 

The total budget per project is $60,000 for 2 years.

 

Key Dates:
Full Application Deadline: February 2 at 11:59 pm (EST)
Notice of Decision: April 2020
Funding Start Date: May 1, 2020

 

All applications are available online at proposalCENTRAL.

Please contact MDC at with any questions or concerns.

mdc-grant-now-open-1200x1200-teal

Read next...

JND treatabolome

Treatabolome Project Designed to Shorten Diagnosis-to-Treatment Time for Patients with Rare Diseases

The NMD4C would like to share the publication of a special issue of the Journal of Neuromuscular Disease dedicated to the Treatabolome, a new online database for rare disease and gene-specific treatment information. The special issue includes six systematic reviews contributed by experts on rare neurological disorders.

MDC_JJ

Neuromuscular Research Funding Announcements From Jesse’s Journey and Muscular Dystrophy Canada

The NMD4C is excited to share recent grant funding announcements from two of our partners, Jesse’s Journey and Muscular Dystrophy Canada. Jesse’s Journey will grant $1.7M toward four promising research projects this year. Muscular Dystrophy Canada (MDC) will invest $400,000 towards seven new research projects through the MDC Neuromuscular Disorder (NMD) Research Grant Competition and through the European Joint Programme on Rare Diseases (EJP RD).

newborn screeningMay

Muscular Dystrophy Canada Announce Phase 2 of Newborn Screening Initiatives with Call for Funding Proposals

MDC is excited to launch Phase 2 of their work with a call for proposals for local newborn screening for SMA initiatives. It is anticipated that these projects will be led by labs or clinicians (or both) and should either focus on setting the lab up for testing or ensuring efficient uptake of policy (i.e., addition of SMA to existing provincial newborn screening panel).

EC Update

Early Career Working Group Update

the NDM4C has created a list of profiles for these members, where you can learn more about their research interests, publications, and where you can find them online. The NMD4C has also launched an early-career Slack channel, and are seeking early career member representation on our work packages.

LM_ECblog

Read Dr. Louise Moyle’s Early Career Blog

Read the latest early career blog post, from NMD4C member Dr. Louise Moyle. 

JJ_logo_EN

Jesse’s Journey Grants $1.7 Million to Duchenne Muscular Dystrophy Research

Jesse’s Journey, Canada’s leader in Duchenne muscular dystrophy funded research, will grant $1.7M toward four promising research projects this year.